Global Consortium, Inc. has begun Manufacturing of Indulge Oils
- Manufacturing of Indulge Pens and Bulk Oil
- The first buy of bio-mass has been completed
- Current order for 20 liters of Oil per day
Coconut Creek, FL -- January 7, 2019 -- InvestorsHub NewsWire -- Global Consortium, Inc., (OTCPINK: GCGX) has begun Manufacturing operations of Indulge Oils.
On Friday January 4, 2019 the first purchase of bio-mass was completed. This will be run through the extraction machines and tested to ensure it meets the States mandated standards. Once the testing is completed than Indulge Oils will begin filling Current orders for 20 liters of Oil at $8,500 per liter.
After fulfillment of some of the bulk Oil orders has been met, Indulge will begin to produce its Pens again and fill those orders which have better margins.
Global Consortium, Inc., in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg. FD.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, release of corporate apps, growth of platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.
Details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure on otcmarkets.com.
For additional information about this release please contact: